bcrm: Bayesian Continual Reassessment Method Designs for Phase I Dose-Finding Trials

This paper presents the R package bcrm for conducting and assessing Bayesian continual reassessment method (CRM) designs in Phase I dose-escalation trials. CRM designsare a class of adaptive design that select the dose to be given to the next recruited patient based on accumulating toxicity data f...

Full description

Bibliographic Details
Published in:	Journal of Statistical Software
Main Authors:	Michael Sweeting, Adrian Mander, Tony Sabin
Format:	Article
Language:	English
Published:	Foundation for Open Access Statistics 2013-09-01
Online Access:	http://www.jstatsoft.org/index.php/jss/article/view/2093

Similar Items

Investigating dose finding methods and different priors in Bayesian continual reassessment method
by: Tuba Koc, et al.
Published: (2020-01-01)

A nonparametric Bayesian continual reassessment method in single-agent dose-finding studies
by: Niansheng Tang, et al.
Published: (2018-12-01)

A placebo-controlled Bayesian dose finding design based on continuous reassessment method with application to stroke research
by: Chunyan Cai, et al.
Published: (2017-09-01)

AplusB: A Web Application for Investigating A + B Designs for Phase I Cancer Clinical Trials.
by: Graham M Wheeler, et al.
Published: (2016-01-01)

Comparison Among Modified Continual Reassessment Methods with Different Dose Allocation Methods for Phase I Clinical Trials
by: Jiacheng Xiao, et al.
Published: (2025-03-01)

A dose-finding design for phase I clinical trials based on Bayesian stochastic approximation
by: Jin Xu, et al.
Published: (2022-10-01)

A novel model of the continual reassessment method in Phase I trial
by: Weijia Zhang, et al.
Published: (2023-03-01)

The continual reassessment method for multiple toxicity grades: a bayesian model selection approach.
by: Haitao Pan, et al.
Published: (2014-01-01)

SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol
by: Sally Hopewell, et al.
Published: (2023-03-01)

A Bayesian tool for optimizing sample size in phase I dose-finding trials for head and neck cancer
by: Sivakamavalli Jeyachandran
Published: (2024-06-01)

A Bayesian dose-finding procedure applied to a seamless phase I/II trial in rheumatoid arthritis
by: Whitehead Anne, et al.
Published: (2011-12-01)

A Bayesian phase 2 model based adaptive design to optimise antivenom dosing: Application to a dose-finding trial for a novel Russell's viper antivenom in Myanmar.
by: James A Watson, et al.
Published: (2020-11-01)

Efficiency of new dose escalation designs in dose-finding phase I trials of molecularly targeted agents.
by: Christophe Le Tourneau, et al.
Published: (2012-01-01)

Implementing the time-to-event continual reassessment method in the presence of partial orders in a phase I head and neck cancer trial
by: Amit Patel, et al.
Published: (2024-01-01)

A Bayesian Adaptive Design in Cancer Phase I Trials Using Dose Combinations with Ordinal Toxicity Grades
by: Márcio A. Diniz, et al.
Published: (2020-07-01)

Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study
by: Olga Solovyeva, et al.
Published: (2023-07-01)

Target toxicity design for phase I dose-finding
by: Wenchuan Guo, et al.
Published: (2021-04-01)

Dose Finding in Oncology Trials Guided by Ordinal Toxicity Grades Using Continuous Dose Levels
by: Mourad Tighiouart, et al.
Published: (2024-08-01)

A Bayesian Adaptive Design in Cancer Phase I Trials Using Dose Combinations in the Presence of a Baseline Covariate
by: Márcio Augusto Diniz, et al.
Published: (2018-01-01)

A clinical phase I dose-finding design with adaptive shrinking boundaries for drug combination trials
by: Zhaohang Li, et al.
Published: (2023-03-01)

Patient and public involvement and engagement in the development of innovative patient-centric early phase dose-finding trial designs
by: Emily Alger, et al.
Published: (2024-06-01)

Implementing the EffTox dose-finding design in the Matchpoint trial
by: Kristian Brock, et al.
Published: (2017-07-01)

Designs for adding a treatment arm to an ongoing clinical trial
by: Maxine Bennett, et al.
Published: (2020-03-01)

Stagnation or safety? Reassessment of the human papillomavirus vaccination dosing regimen in Japan
by: Mira Namba, et al.
Published: (2023-12-01)

Enhancing phase I dose-finding trials design through dynamic borrowing information and handling late-onset toxicity
by: Wenyun Yang, et al.
Published: (2023-11-01)

TRAFIC: statistical design and analysis plan for a pragmatic early phase 1/2 Bayesian adaptive dose escalation trial in rheumatoid arthritis
by: M. Cole, et al.
Published: (2021-07-01)

Practicalities in running early-phase trials using the time-to-event continual reassessment method (TiTE-CRM) for interventions with long toxicity periods using two radiotherapy oncology trials as examples
by: Erik van Werkhoven, et al.
Published: (2020-06-01)

Reassessment of Gene-Elusive Familial Dilated Cardiomyopathy Leading to the Discovery of a Homozygous AARS2 Variant—The Importance of Regular Reassessment of Genetic Findings
by: Priya Bhardwaj, et al.
Published: (2021-07-01)

Design of a phase II randomised, double-blind, placebo-controlled, dose-finding trial of BI 1819479 in patients with idiopathic pulmonary fibrosis
by: Wim A. Wuyts, et al.
Published: (2026-03-01)

Bottlenecks in the development of topical analgesics: molecule, formulation, dose-finding, and phase III design
by: Keppel Hesselink JM, et al.
Published: (2017-03-01)

SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocolsResearch in context
by: Moreno Ursino, et al.
Published: (2025-01-01)

CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trialsResearch in context
by: Jan Rekowski, et al.
Published: (2025-01-01)

Sample Size Reassessment and Hypothesis Testing in Adaptive Survival Trials.
by: Dominic Magirr, et al.
Published: (2016-01-01)

A Reassessment of the Adaptation of West Old Turkic Loanwords in Hungarian: New Findings and Perspectives
by: Ali Can Yalçınkaya, et al.
Published: (2026-01-01)

A reassessment of the Neotropical Cyathea pungens complex (Cyatheaceae)
by: Marcus Lehnert, et al.
Published: (2025-04-01)

Understanding the Role of Patient-Reported Outcomes for Decision-Making in Early-Phase Dose-Finding Clinical Trials
by: Richard Brown, et al.
Published: (2025-03-01)

Majoritarian Democracy Reassessed
by: Shuja Shakir
Published: (2020-03-01)

Reassessing the Gold Standard
by: Mark Justine Bansil
Published: (2026-06-01)

Educational Assessment Reassessed
by: William L. Sanders, et al.
Published: (1995-03-01)

Optimizing dose-schedule regimens with bayesian adaptive designs: opportunities and challenges
by: Xin Chen, et al.
Published: (2023-11-01)